The Peptide Desk The Peptide Desk

This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon
Weight management

SUPER SHRED

Lipotropic injection formula designed to support fat loss research within GLP-1 frameworks.

1 min read 7 sources

To the product To the sources
Vial with golden oil, blue cap and the black TPD label of SUPER SHRED on a white podium, next to it floating blue 3D molecules
No study of its own · not approved

Summary

At a glance

Sources checked on 26 Oct 2026

On the formula itself
0 studies

neither in the trial registry nor in PubMed, as of 26 Oct 20265

Lean mass with salbutamol
+1.8 kg

more than placebo, 11 weeks of strength training, tablets at a high amount1

Maximal oxygen uptake
-7 %

clenbuterol, 2 weeks; fat mass unchanged2

Resting metabolic rate with beta-2 agonists
bis +50 %

10 to 50% higher depending on the amount, review3

  • SUPER SHRED is a lipotropic injection formula in oil. As its mode of action the entry mainly names beta-2 agonist effects, it does not name the exact composition.
  • There is no study on the formula itself, neither in the trial registry nor in PubMed. Beta-2 agonists such as salbutamol and clenbuterol have been studied as tablets.56
  • In two randomised trials young men gained lean mass: 1.8 kg more than placebo with salbutamol over 11 weeks, 0.91 kg with clenbuterol over 2 weeks. Fat mass did not change on clenbuterol.12
  • The downside: endurance fitness suffered, the muscles lost oxidative capacity and on salbutamol heart walls got thicker on ultrasound.21
  • The formula is not approved. Everything here is the state of research, not a recommendation.5
Profile

Updated June 2026

Class
Lipotropic injection formula
Use
Fat loss research
Form
Oil

553mg/ml

Status
Research substance
Sizes
553mg/ml

1 size in the shop

Contents 12 sections
  1. At a glance
  2. What is SUPER SHRED?
  3. How it works
  4. Application and dosing
  5. What the research shows
  6. Research status
  7. Side effects
  8. Storage
  9. Related compounds
  10. FAQ
  11. Glossary
  12. Sources

What is SUPER SHRED?

SUPER SHRED is an injection formula used in fat loss research contexts. The formula is supplied at 553mg/ml concentration in an oil carrier base. It contains active ingredients used in research protocols to study fat loss mechanisms and metabolic effects.

This information is for research and educational purposes only. No medical advice.

Comparison

Beta-2 agonists and lipotropic formulas

Related products in the TPD lexicon, as described there. Tap a card to open its entry.

Oil, with a beta-2 agonist per the entry SUPER SHRED Beta-2
Beta-2 agonist, short-acting Salbutamol Beta-2 Beta-2 agonist, long-acting Clenbuterol Beta-2 Oil, composition not named SHRED

For SUPER SHRED the lexicon does not name the composition, only beta-2 agonist effects. There is no study on the formula itself. 57

How it works

Lipotropic formulas support fat metabolism through multiple mechanistic pathways. In research protocols, such blends are used to examine metabolic parameters and body composition changes. The mechanisms typically involve beta-2 agonist activity and metabolic modulation. Research data on the exact mechanism of action for this proprietary blend is limited.

Where it acts

One receptor, several organs

Tap a point or a card. Colour = beta-2 receptor, grey = seen in studies. Data on single compounds, not on the formula.

  1. Skeletal muscle

    More lean mass, but fewer capillaries and oxidative enzymes (salbutamol)1

    Beta-2
  2. Heart

    Thicker heart walls on ultrasound, no difference on MRI (salbutamol)1

    Observed in trials
  3. Airways

    Salbutamol is approved as a medicine for the airways7

    Beta-2
  4. Fat tissue

    Resting metabolic rate 10 to 50% higher depending on the amount (review)3

    Observed in trials

Targets in the ChEMBL database7

Compound CHEMBL714: one recorded mechanism, agonist with direct binding to the human receptor.

Beta-2 adrenergic receptor
Gene
ADRB2
UniProt
P07550
ChEMBL
CHEMBL210
Action
Agonist, direct binding
Glassy fat cells with golden cores, blue 3D molecules docking onto their surface
Beta-2 agonists dock onto receptors on the cell surface. Symbolic image.

Application and dosing

Dosing

Dosing, titration and syringe

Loading the dosing information …

  • Getting started and stepping up, drawn as a staircase
  • Units on the U-100 syringe for every step
  • How long one vial lasts
SUPER SHRED vial with golden oil and the black TPD label, next to it a disposable syringe on a white surface
Oil carrier, injection per research protocol. Symbolic image.

What the research shows

Studies on lipotropic blends are limited. Research in this area typically focuses on individual components like carnitine, choline compounds and beta-2 agonists, each with separate mechanisms for fat loss support. Combination studies examining synergy between components are lacking for most proprietary blends.

Study results

What the trials measured

Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.

More lean mass than on placebo12

Difference to placebo in kg, randomised trials in healthy young men

Salbutamol, 11 weeks1 30 trained men, 26 to the end, full-body strength training
Salbutamol tablets, 11 weeks with strength training +1.80 kg
Clenbuterol, 2 weeks2 11 healthy men, crossover with placebo
Clenbuterol tablets, 2 weeks +0.91 kg

Measured by body scan (DXA). Fat mass stayed the same on clenbuterol. Both trials used tablets, no injection and no blend.

Endurance and fitness21

Change in percent

Maximal oxygen uptake2 Clenbuterol versus placebo
Clenbuterol tablets, 2 weeks -7%
Exercise capacity2 Clenbuterol versus placebo
Clenbuterol tablets, 2 weeks -4%
Time to exhaustion1 after 11 weeks of training
Salbutamol tablets, 11 weeks with strength training 0%
Placebo with the same training +7%

With placebo training improved endurance, with salbutamol it did not. In the muscles capillary density and oxidative enzymes fell.

Weight and fat mass with L-carnitine4

Difference to control in kg, 37 randomised trials, typical component of lipotropic formulas

Body weight4
L-carnitine by mouth (meta-analysis) -1.21 kg
Fat mass4
L-carnitine by mouth (meta-analysis) -2.08 kg

Whether SUPER SHRED contains L-carnitine is not stated in the lexicon. The entry only names carnitine as a typical component of such formulas.

Petri dish with pale tissue under a microscope, a droplet falling from the objective
There is no study on the formula, only data on single compounds. Symbolic image.

Research status

Where the research stands

There is no registered trial on the formula. Because the entry does not name the components, the research status shows no trials on single compounds. As of 26 Oct 2026.

  1. Preclinical Beta-2 agonists: more muscle and less fat in livestock and rodents
  2. Phase 1 no registered trial
  3. Phase 2 no registered trial
  4. Phase 3 no registered trial
  5. Approval not yet
The formula is not approved. ChEMBL lists salbutamol (albuterol) as an approved drug since 1981, as a medicine for the airways.5

So far there is no registered trial in humans.

Side effects

  • Cardiovascular: Beta-2 agonists can increase heart rate, tremor and headache
  • Local: Swelling, pain, or erythema at injection site
  • Systemic: Insomnia, nervousness, blood pressure changes
  • Long-term data: Limited safety data available for this proprietary formulation

Storage

Store at room temperature, protected from light. Refrigeration is not required. Keep bottle tightly capped after use. Visually inspect for particulates before use. Use within 8 weeks of opening.

Four glass vials with golden oil on a white shelf, next to a folded light blue cloth
Room temperature, protected from light, use within 8 weeks of opening. Symbolic image.

Related

Related compounds

Same receptors or a different path: all in the TPD lexicon.

SUPER SHRED
Salbutamol Beta-2 agonist, albuterol is the same compound Clenbuterol Beta-2 agonist with a long half-life SHRED Second fat-loss formula in oil L-Carnitine Typical component of lipotropic formulas Lipo-C FAT BLASTER Lipotropic blend with L-carnitine Lipo Mino Mix Lipotropic mix in oil

FAQ

Common questions about SUPER SHRED

Short answers, each backed by the sources below.

Are there studies on SUPER SHRED?

No. As of 26 October 2026 there is no study on the formula, neither on ClinicalTrials.gov nor in PubMed. Only single compounds have been studied: beta-2 agonists as tablets and L-carnitine by mouth.56

What is in SUPER SHRED?

According to the lexicon active ingredients for fat loss research in an oil carrier. As its mode of action the entry typically names beta-2 agonist effects, with albuterol listed as a search term, internationally called salbutamol. The entry does not name which compounds are included or in what amounts.

What do beta-2 agonists do in healthy people?

They raise resting metabolic rate by 10 to 50 percent depending on the amount. In a randomised trial 30 trained men on salbutamol tablets built 1.8 kg more lean mass over 11 weeks than on placebo. With clenbuterol it was 0.91 kg after 2 weeks, fat mass stayed the same there.312

Which downsides did these trials show?

Endurance suffered. On clenbuterol maximal oxygen uptake fell by 7 percent and exercise capacity by 4 percent. With salbutamol training did not improve endurance, with placebo it did by 7 percent. In the muscles capillary density and oxidative enzymes fell, on ultrasound heart walls got thicker. The signalling effect in muscle already faded within the 2 weeks on clenbuterol.21

What is known about L-carnitine?

A meta-analysis of 37 randomised trials found on average 1.21 kg less body weight and 2.08 kg less fat mass than in the control groups, taken by mouth. Whether SUPER SHRED contains L-carnitine is not stated in the lexicon.4

Which side effects does the entry name?

There are no study data for the formula. For beta-2 agonists the entry names a faster heart rate, tremor and headache, plus insomnia, nervousness and blood pressure changes as well as reactions at the injection site.

Is SUPER SHRED approved?

No, SUPER SHRED is a research substance. According to ChEMBL salbutamol has been an approved drug since 1981, as a medicine for the airways, but that says nothing about the formula. Everything here is the state of research, not a recommendation.7

Glossary

Terms explained briefly

Dotted words in the text open these explanations directly.

Beta-2 agonist
Compound that activates the beta-2 receptor. It widens the airways and stimulates metabolism and muscle.
Cardiovascular
Relating to the heart and blood vessels.
L-carnitine
A substance made by the body that carries fatty acids into the mitochondria, where they are burned.
Lean mass
Body weight without fat and bone, mainly muscle, organs and water.
Lipotropic
Substances involved in fat metabolism and fat transport in the liver, for example choline, methionine, inositol or carnitine.
Maximal oxygen uptake
The most oxygen the body can take up at full effort. A measure of endurance.
Randomised
Assigned to the groups by chance. That way the groups differ only by the treatment.
Resting metabolic rate
The energy the body uses at rest.
Salbutamol (albuterol)
Short-acting beta-2 agonist, approved as an asthma medicine. In the USA it is called albuterol.
Tremor
Involuntary shaking, for example of the hands. Typical for beta-2 agonists.

Evidence

Sources

Show all 7 sourcesHide sources 4 Studies1 Trial registry2 Database checked 26 Oct 2026

Studies

  1. High-dose salbutamol during strength training: lean mass, heart and muscle

    Hostrup et al., Scandinavian Journal of Medicine & Science in Sports, 2026

    DOI 10.1111/sms.70302 PMID 42274909
    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  2. Clenbuterol: more lean mass, less endurance fitness

    Hostrup et al., Journal of Physiology, 2025

    DOI 10.1113/JP289023 PMID 40946331
    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  3. The beta-2 receptor as a target against obesity (review)

    Hostrup & Onslev, Journal of Physiology, 2022

    DOI 10.1113/JP281819 PMID 34676534
    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  4. Meta-analysis: L-carnitine, weight and body composition

    Talenezhad et al., Clinical Nutrition ESPEN, 2020

    DOI 10.1016/j.clnesp.2020.03.008 PMID 32359762
    Checked 26 Oct 2026 via doi.org, Crossref, PubMed

Trial registry

  1. Registry search for the formula and lipotropic injections (0 results)

    ClinicalTrials.gov, U.S. National Library of Medicine

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2

Database

  1. PubMed search for the formula (0 results)

    PubMed, U.S. National Library of Medicine

    Checked 26 Oct 2026 via PubMed E-utilities
  2. Salbutamol (albuterol) in ChEMBL

    ChEMBL, EMBL-EBI (CHEMBL714)

    Checked 26 Oct 2026 via ChEMBL

In the shop

SUPER SHRED in the catalog

Sizes, prices and shipping times are on the product page.

To the product